September 21, 2017 8:53 AM ET

Pharmaceuticals

Company Overview of Phibro Animal Health Corporation

Executive Profile

Sam Gejdenson

Independent Non-Executive Director, Phibro Animal Health Corporation
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 organization across 3 different industries.

See Board Relationships
68$60,000

Background

Mr. Samuel Gejdenson, also known as Sam, served as Vice President of Governmental Affairs at Eagle Building Technologies, Inc. Mr. Gejdenson is involved in international trade in his own company Sam Gejdenson International. Mr. Gejdenson has been an Independent Non Executive Director of Phibro Animal Health Corporation (formerly known as Philipp Brothers Chemicals Inc.) since January 2004. He serves as a Director of Phibro Animal Health S.A. Mr. Gejdenson served as a ...

Corporate Headquarters

Glenpointe Centre East
Teaneck, New Jersey 07666

United States

Phone: 201-329-7300
Fax: 201-329-7399

Board Members Memberships

Director
2004-Present
Independent Non-Executive Director

Education

BA
University of Connecticut
Unknown/Other Education 1968
Mitchell College
AS
Mitchell College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$60,000
Total Calculated Compensation$60,000
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ian D. Page CEO, MD & Executive Director
Dechra Pharmaceuticals plc
$941.0K
Matthieu Frechin CEO & Director
Vétoquinol SA
$421.6K
Éric Marée Chairman of Executive Board & President
Virbac SA
$406.1K
Steven St. Peter M.D.Co-Founder, Chief Executive Officer, President & Director
Aratana Therapeutics, Inc.
$467.5K
Robert T. Joseph President, Chief Executive Officer & Director
Parnell Pharmaceuticals Holdings Ltd
--
Compensation as of Fiscal Year 2017.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Phibro Animal Health Corporation, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.